Market Overview:
The global beta-2 microglobulin (B2M) market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of chronic diseases and rising demand for B2M tests for early diagnosis and treatment. In addition, growing awareness about the benefits of early diagnosis is also propelling the growth of this market. Based on type, the global beta-2 microglobulin (B2M) market has been segmented into purity, ≥98%, purity, ≥95%, and others. The purity, ≥98% segment is expected to account for a major share of the global B2M market in 2018 owing to its high accuracy and reliability in diagnosing various diseases. By application, ELISA accounted for a major share of the global B2M market in 2017 and is projected to maintain its dominance during the forecast period.
Product Definition:
A protein that is produced in the liver and is present in the blood. Beta-2 microglobulin helps to regulate the immune system.
Purity,≥98%:
Purity, %98%, it's usage and growth factor in Beta-2 Microglobulin (B2M) market? The global B2M purity is increasing year on year with the advancements in technology. The manufacturers are constantly striving to achieve 100% product purity which has led to high quality standards for the finished products.
Purity,≥95%:
Purity, 95% is a kind of protein purification process. It's used for the separation of proteins from other contaminants in pharmaceutical and biopharmaceutical products. The purity percentage refers to the concentration of protein in a product or final mixture. It helps determine how much protein is present in a particular sample and also helps check that all samples have an equal amount of protein content.
Application Insights:
The ELISA method of testing is used for the detection of Beta-2 Microglobulin (B2M) in pharmaceutical and biopharmaceutical products. The Western Blotting technique is used to detect the presence of B2M protein in tissue samples.
Infectious disease testing dominated the application landscape with respect to revenue share at over 24% in 2017 owing to a rise in demand for rapid diagnostic tests that can specifically target microorganisms associated with diseases such as HIV, hepatitis A & B viruses, tuberculosis bacteria etc.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate of technologically advanced products are some factors responsible for its large share. Moreover, increasing cases of cancer is also expected to drive the regional demand for B2M over the forecast period. In addition, rising government initiatives to increase awareness regarding diagnostic techniques such as western blotting and ELISA are anticipated to propel industry growth in this region during the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to various factors such as improving healthcare facilities due primary health care approach towards diagnosis rather than cure.
Growth Factors:
- Increasing incidence of chronic kidney diseases (CKDs) and diabetes mellitus (DM)
- Rising awareness about the benefits of B2M therapy
- Growing demand for novel therapeutics for the treatment of CKDs and DM
- Technological advancements in B2M assay kits and platforms
- Expansion of distribution channels by key players
Scope Of The Report
Report Attributes
Report Details
Report Title
Beta-2 Microglobulin (B2M) Market Research Report
By Type
Purity,≥98%, Purity,≥95%, Others
By Application
ELISA, Flow Cytometry, Western Blotting, Others
By Companies
Bio-Rad, Lee Biosolutions, Abcam, Prospec-Tany Technogene Ltd, Tosoh, Fosun Pharmaceutical, Wuhan Huamei Biotech Co
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
211
Number of Tables & Figures
148
Customization Available
Yes, the report can be customized as per your need.
Global Beta-2 Microglobulin (B2M) Market Report Segments:
The global Beta-2 Microglobulin (B2M) market is segmented on the basis of:
Types
Purity,≥98%, Purity,≥95%, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
ELISA, Flow Cytometry, Western Blotting, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad
- Lee Biosolutions
- Abcam
- Prospec-Tany Technogene Ltd
- Tosoh
- Fosun Pharmaceutical
- Wuhan Huamei Biotech Co
Highlights of The Beta-2 Microglobulin (B2M) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity,≥98%
- Purity,≥95%
- Others
- By Application:
- ELISA
- Flow Cytometry
- Western Blotting
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Beta-2 Microglobulin (B2M) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Beta-2 Microglobulin is a protein that helps the body to fight infection.
Some of the major companies in the beta-2 microglobulin (b2m) market are Bio-Rad, Lee Biosolutions, Abcam, Prospec-Tany Technogene Ltd, Tosoh, Fosun Pharmaceutical, Wuhan Huamei Biotech Co.
The beta-2 microglobulin (b2m) market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Beta-2 Microglobulin (B2M) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Beta-2 Microglobulin (B2M) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Beta-2 Microglobulin (B2M) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Beta-2 Microglobulin (B2M) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Beta-2 Microglobulin (B2M) Market Size & Forecast, 2020-2028 4.5.1 Beta-2 Microglobulin (B2M) Market Size and Y-o-Y Growth 4.5.2 Beta-2 Microglobulin (B2M) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity
5.2.2 ≥98%
5.2.3 Purity
5.2.4 ≥95%
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 ELISA
6.2.2 Flow Cytometry
6.2.3 Western Blotting
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Beta-2 Microglobulin (B2M) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Beta-2 Microglobulin (B2M) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity
9.6.2 ≥98%
9.6.3 Purity
9.6.4 ≥95%
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 ELISA
9.10.2 Flow Cytometry
9.10.3 Western Blotting
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity
10.6.2 ≥98%
10.6.3 Purity
10.6.4 ≥95%
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 ELISA
10.10.2 Flow Cytometry
10.10.3 Western Blotting
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity
11.6.2 ≥98%
11.6.3 Purity
11.6.4 ≥95%
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 ELISA
11.10.2 Flow Cytometry
11.10.3 Western Blotting
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity
12.6.2 ≥98%
12.6.3 Purity
12.6.4 ≥95%
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 ELISA
12.10.2 Flow Cytometry
12.10.3 Western Blotting
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity
13.6.2 ≥98%
13.6.3 Purity
13.6.4 ≥95%
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 ELISA
13.10.2 Flow Cytometry
13.10.3 Western Blotting
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Beta-2 Microglobulin (B2M) Market: Competitive Dashboard
14.2 Global Beta-2 Microglobulin (B2M) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad
14.3.2 Lee Biosolutions
14.3.3 Abcam
14.3.4 Prospec-Tany Technogene Ltd
14.3.5 Tosoh
14.3.6 Fosun Pharmaceutical
14.3.7 Wuhan Huamei Biotech Co